Publication | Closed Access
A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia
19
Citations
18
References
2010
Year
Hematological MalignancyMedicineAcute Myeloid LeukemiaImmunologyHematologyMyeloid NeoplasiaAdult T-cell Leukemia-lymphomaOncologyRadiation OncologyPhase 1Imatinib MesylateCancer ResearchHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1